Concepedia

S Knapik

SK

Statistics

Publications

5

Citations

616

H-Index

5

Active since

1996

Affiliations

C2N Diagnostics (United States)(Current)

Hope Center for Neurological Disorders

S Knapik is an author at C2N Diagnostics (United States) specializing in neurodegeneration, neurology, and dementia biomarkers.

Publications per year

1996–2022

5

Publications

5

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

Tim West, Kristopher M. Kirmess, Matthew R. Meyer et al. · Molecular Neurodegeneration · 2021 · 232 citations · Full text

, , +17

Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment

Yan Hu, Kristopher M. Kirmess, Matthew R. Meyer et al. · JAMA Network Open · 2022 · 136 citations · Full text

, , +17

The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis

Kristopher M. Kirmess, Matthew R. Meyer, Mary S. Holubasch et al. · Clinica Chimica Acta · 2021 · 133 citations · Full text

, , +17

Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy

Kiran Yanamandra, Tirth K. Patel, Hong Jiang et al. · Science Translational Medicine · 2017 · 99 citations

, , +6

Diabetic neuropathic cachexia.

Aslam Godil, D. J. Berriman, S Knapik et al. · PubMed · 1996 · 16 citations

1–5 of 5